Inergetics Inc (OTCMKTS:NRTI) is dropping heavily on big volume since falling below $0.01 in recent days. The stock does have a history of big moves running from a start point of $0.10 to a high of $0.34 a share in 2014.
In recent news NRTI announced many of its products are now available in 165 Weis Markets. “By gaining distribution into Weis Markets we have effectively extended and deepened our penetration into suburban and rural communities uniquely served by Weis,” stated Mike James, CEO of Inergetics. “Our distribution growth continues to accelerate on target with our expansion goals. Furthermore, we are proud to be associated with Weis Markets given their strong focus on serving their local communities.”
Inergetics Inc (OTCMKTS:NRTI) is a leading developer of advanced proprietary nutritional products that improve overall health, physical recovery, athletic performance and quality of life for patients and consumers. These product lines include:
Martha Stewart Essentials, the first branded line of women’s supplements on the market specifically crafted with Martha’s special touch.
Surgex Sports Nutrition, with its pioneering formulas developed to meet the nutritional needs of the masses as well as professional and amateur athletes. Surgex is proud to be the preferred sports nutrition brand for Army Sports, San Diego Charger wide receiver and 2013 NFL Offensive Player of the Year Keenan Allen, and David Amerson, star cornerback of the Washington Redskins.
To Find out the inside Scoop on NRTI Subscribe to Microcapdaily.com Right Now by entering your Email in the box below
Bikini Ready Lifestyle, an innovative formula used by professional surfers Anastasia Ashley and Christa Alves to help you maintain your weight and get you “Bikini Ready”!
SlimTrim, an affordable, premium value diet supplement to help you maintain a healthy lifestyle in order to lose those extra pounds.
On February 23 NRTI announced it is completing the final development phase for its new Cannabidiol (CBD)-based pain relief product.
Following a meeting with its CBD Initiative Scientific/Medical Advisory Board last November, the company has marked significant progress in readying its first natural CBD-based nutraceutical supplement for introduction to the marketplace. With the product’s formulation, dosage, naming, brand identity, and regulatory work largely done as well as initial distribution arrangements in place, Inergetics will launch its innovative new pain relief product in the first quarter of 2015.
CEO of NRTI Mike James said “We have made tremendous progress over the last few months toward bringing a truly new pain relief solution to the market. We believe the work of the Inergetics team and CBD Initiative Scientific/Advisory Board produced a breakthrough supplement line that marries our ability to develop innovative, natural nutraceuticals with a science-based approach leveraging CBD’s proven benefits to the human body. The product line is intended to improve the lives of people suffering from pain by giving them a natural remedy that is holistic, opiate-free, non-addictive and effective.”
He continued “Our unique pain relief brand also benefits from the proven technological excellence and extensive brand support we bring to our entire portfolio of leading supplements,” James added. “We look forward to debuting our product and all its valuable attributes at our upcoming launch event while simultaneously beginning a conversation with physicians, their patients and our stakeholders about the future of pain relief.”
We have a Monster Pick Coming. Subscribe Right Now!
Currently trading at a $1.3 million market valuation NRTI has minimal assets or debt with small but growing revenues. The Company has been highly successful in attracting a loyal shareholder base that supports the stocks and believes it goes way higher as the Company has been working overtime announcing many of its products are now available in 165 Weis Markets. We will be updating on NRTI when more details emerge so make sure you are subscribed to Microcapdaily so you know what’s going on with NRTI.
Sign Up now for our 100% FREE Penny Stock Newsletter
Disclosure: we hold no position in NRTI either long or short and we have not been compensated for this article.